Zahid H. Siddik

11.8k total citations · 3 hit papers
154 papers, 9.4k citations indexed

About

Zahid H. Siddik is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Zahid H. Siddik has authored 154 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 55 papers in Molecular Biology and 34 papers in Organic Chemistry. Recurrent topics in Zahid H. Siddik's work include Metal complexes synthesis and properties (58 papers), Ferrocene Chemistry and Applications (31 papers) and Cancer-related Molecular Pathways (22 papers). Zahid H. Siddik is often cited by papers focused on Metal complexes synthesis and properties (58 papers), Ferrocene Chemistry and Applications (31 papers) and Cancer-related Molecular Pathways (22 papers). Zahid H. Siddik collaborates with scholars based in United States, United Kingdom and Canada. Zahid H. Siddik's co-authors include David R. Newell, Abdul R. Khokhar, Frances Boxall, A. Hilary Calvert, E. Wiltshaw, Martin Gore, Lindsey Gumbrell, Ian Judson, Séamus O’Reilly and Matthew Burnell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Zahid H. Siddik

153 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin: mode of cytotoxic action and molecular basis of resistance

2003 2.8k citations Zahid H. Siddik Oncogene profile →
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

1989 1.5k citations A. Hilary Calvert, David R. Newell et al. Journal of Clinical Oncology profile →
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II

1982 408 citations A. Hilary Calvert, David R. Newell et al. Cancer Chemotherapy and Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zahid H. Siddik United States	39	4.6k	3.8k	1.7k	1.3k	1.1k	154	9.4k
David R. Newell United Kingdom	49	5.0k 1.1×	5.1k 1.3×	1.3k 0.8×	1.4k 1.1×	1.3k 1.2×	206	10.2k
Enrico Mini Italy	50	5.2k 1.1×	3.2k 0.8×	1.2k 0.7×	2.0k 1.5×	1.1k 1.0×	251	10.1k
Merrill J. Egorin United States	66	5.5k 1.2×	5.9k 1.5×	1.6k 1.0×	500 0.4×	2.2k 2.0×	380	14.2k
Esteban Cvitkovic France	57	5.5k 1.2×	2.8k 0.7×	1.5k 0.9×	561 0.4×	2.7k 2.5×	216	10.3k
Duncan I. Jodrell United Kingdom	51	7.3k 1.6×	4.0k 1.0×	626 0.4×	2.1k 1.7×	951 0.9×	166	11.3k
Paola Perego Italy	47	4.2k 0.9×	5.8k 1.5×	628 0.4×	905 0.7×	1.3k 1.2×	177	9.2k
Lloyd R. Kèlland United Kingdom	57	7.0k 1.5×	8.1k 2.1×	887 0.5×	4.3k 3.4×	1.1k 1.0×	176	15.3k
Beverly A. Teicher United States	67	7.5k 1.7×	8.7k 2.3×	927 0.6×	946 0.7×	2.3k 2.1×	396	18.1k
Hilde Rosing Netherlands	56	6.7k 1.5×	4.6k 1.2×	532 0.3×	503 0.4×	1.5k 1.4×	422	13.3k
Alan Eastman United States	61	5.2k 1.1×	9.0k 2.3×	807 0.5×	1.4k 1.1×	572 0.5×	185	12.5k

Countries citing papers authored by Zahid H. Siddik

Since Specialization

Citations

This map shows the geographic impact of Zahid H. Siddik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zahid H. Siddik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zahid H. Siddik more than expected).

Fields of papers citing papers by Zahid H. Siddik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zahid H. Siddik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zahid H. Siddik. The network helps show where Zahid H. Siddik may publish in the future.

Co-authorship network of co-authors of Zahid H. Siddik

This figure shows the co-authorship network connecting the top 25 collaborators of Zahid H. Siddik. A scholar is included among the top collaborators of Zahid H. Siddik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zahid H. Siddik. Zahid H. Siddik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Bangxing, Uksha Saini, David E. Cohn, et al.. (2020). Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity. Clinical Cancer Research. 27(2). 542–553. 23 indexed citations

He, Guangan, Xiaolei Xie, & Zahid H. Siddik. (2020). Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents. Cancer Chemotherapy and Pharmacology. 85(6). 1129–1140. 2 indexed citations

Farooqı, Ammad Ahmad, Marc de la Roche, Mustafa B.A. Djamgoz, & Zahid H. Siddik. (2019). Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights. Seminars in Cancer Biology. 58. 65–79. 121 indexed citations

Thiabaud, Grégory, Jonathan F. Arambula, Zahid H. Siddik, & Jonathan L. Sessler. (2014). Photoinduced Reduction of Pt^IV within an Anti‐Proliferative Pt^IV–Texaphyrin Conjugate. Chemistry - A European Journal. 20(29). 8942–8947. 34 indexed citations

Kim, Eric S., J. Jack Lee, Guangan He, et al.. (2012). Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(27). 3345–3352. 81 indexed citations

Chimento, Melissa F., et al.. (2007). Lipoprotein-Like Particles Represent a Major Portion of Lipids Found in Human Macular Bruch’s Membrane (BrM). Investigative Ophthalmology & Visual Science. 48(13). 2185–2185. 3 indexed citations

Lü, Yang, Xinqun Li, Ke Liang, et al.. (2007). Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance to the anti-EGFR monoclonal antibody cetuximab. Cancer Research. 67. 4082–4082. 3 indexed citations

Kuang, Jian, et al.. (2006). Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21. British Journal of Cancer. 95(11). 1514–1524. 40 indexed citations

He, Guangan, Zahid H. Siddik, Ruoning Wang, et al.. (2005). Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene. 24(18). 2929–2943. 219 indexed citations

10.

Song, Im‐Sook, Niramol Savaraj, Zahid H. Siddik, et al.. (2004). Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Cancer Research. 65. 347–347. 6 indexed citations

11.

Siddik, Zahid H.. (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22(47). 7265–7279. 2774 indexed citations breakdown →

12.

Whitmire, Kenton H., et al.. (1999). Preparation, characterization, and antitumor activity of new cisplatin analogs with homopiperazines: crystal structure of [PtII(1-methylhomopiperazine)(methylmalonato)]·2H2O. Journal of Inorganic Biochemistry. 77(3-4). 231–238. 29 indexed citations

13.

Wondergem, J., F. R. Strebel, L. Clifton Stephens, Zahid H. Siddik, & J. M. C. Bull. (1995). Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat. International Journal of Hyperthermia. 11(1). 37–47. 5 indexed citations

14.

Khokhar, Abdul R., Yuanjian Deng, Salaam Al-Baker, Motofumi Yoshida, & Zahid H. Siddik. (1993). Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes. Journal of Inorganic Biochemistry. 51(3). 677–687. 53 indexed citations

15.

Ohno, Shinji, F. R. Strebel, L. Clifton Stephens, et al.. (1992). Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.. PubMed. 52(15). 4096–101. 14 indexed citations

16.

Calvert, A. Hilary, David R. Newell, Lindsey Gumbrell, et al.. (1989). Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of Clinical Oncology. 7(11). 1748–1756. 1510 indexed citations breakdown →

17.

Siddik, Zahid H. & Robert A. Newman. (1989). Metabolism of new anticancer agents. Pharmacology & Therapeutics. 41(1-2). 163–194. 1 indexed citations

18.

Siddik, Zahid H., Frances Boxall, A. Hilary Calvert, & Kenneth R. Harrap. (1985). Use of a solubilisation procedure in the determination of platinum (Pt) in rodent and human tissues following carboplatin (JM8, CBDCA) administration. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations

19.

Siddik, Zahid H., David R. Newell, Mark Jones, & Frances Boxall. (1982). Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8) in mice and rats. Proceedings of the American Association for Cancer Research. 23. 4 indexed citations

20.

Šikić, Branimir I., et al.. (1981). Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.. PubMed. 64(4-5). 659–67. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact